Date published: 2025-9-9

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olfr770 Inhibitors

Olfr770, a member of the olfactory receptor family within the G-protein-coupled receptor (GPCR) superfamily, plays a pivotal role in the olfactory system of Mus musculus (house mouse). Similar to other olfactory receptors, Olfr770 is integral to the detection and transduction of odorant molecules, triggering a neuronal response that underlies the perception of smell. This receptor, like its counterparts, possesses a 7-transmembrane domain structure crucial for its functionality in recognizing diverse odorant molecules and activating associated G proteins, thereby initiating intracellular signaling cascades leading to neuronal excitation.

The modulation of Olfr770's function, particularly through inhibition, can be approached via indirect mechanisms due to the intricate nature of GPCR signaling networks and the lack of direct inhibitors. The chemical inhibitors listed, primarily beta-adrenergic receptor antagonists and angiotensin II receptor blockers, serve as potential indirect modulators of Olfr770's activity. These inhibitors operate by altering the signaling dynamics within the GPCR family. For instance, beta-adrenergic receptor antagonists such as bisoprolol and esmolol specifically target beta-1 adrenergic receptors, leading to changes in the adrenergic signaling which could, in turn, affect the signaling pathways related to olfactory receptors. Similarly, angiotensin II receptor antagonists like candesartan and valsartan modulate the angiotensin receptor pathways, which might influence the olfactory receptor functions through altered receptor interactions and systemic signaling modifications. In summary, the inhibition of Olfr770 involves leveraging the broader GPCR signaling networks and understanding the complex interplay between different receptor types. The indirect modulation of Olfr770 through chemical inhibitors underscores the potential for targeted interventions in the realm of sensory perception. This approach highlights the complexity of GPCR signaling and the interconnected nature of cellular signaling mechanisms, providing a window into the modulation of olfactory receptors and the intricacies of olfactory perception.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bisoprolol

66722-44-9sc-278792
25 mg
$204.00
(0)

Bisoprolol is a selective beta-1 adrenergic receptor antagonist. Its specific inhibition of beta-1 receptors can lead to altered GPCR signaling dynamics, potentially impacting olfactory receptor function by modulating G protein-coupled processes.

Candesartan

139481-59-7sc-217825
sc-217825B
sc-217825A
10 mg
100 mg
1 g
$46.00
$92.00
$148.00
6
(1)

Candesartan is an angiotensin II receptor antagonist. By blocking angiotensin receptors, it can indirectly affect GPCR signaling, potentially influencing the activity of olfactory receptors through altered receptor interactions.

Irbesartan

138402-11-6sc-218603
sc-218603A
10 mg
50 mg
$104.00
$297.00
3
(1)

Irbesartan, an angiotensin II receptor antagonist, modulates cardiovascular function. Its action can indirectly influence GPCR-mediated pathways, including olfactory receptors, by modulating systemic signaling interactions.

Esmolol

81147-92-4sc-279019B
sc-279019A
sc-279019
50 mg
100 mg
500 mg
$100.00
$150.00
$650.00
1
(1)

Esmolol is a selective beta-1 adrenergic receptor blocker. Its action on cardiac receptors can indirectly impact GPCR signaling pathways, including those of olfactory receptors, through systemic modulation of adrenergic signaling.

Telmisartan

144701-48-4sc-204907
sc-204907A
50 mg
100 mg
$71.00
$92.00
8
(1)

Telmisartan is an angiotensin II receptor blocker with anti-hypertensive properties. Its blockade of angiotensin receptors can indirectly influence GPCR dynamics, potentially affecting olfactory receptor function.

Valsartan

137862-53-4sc-220362
sc-220362A
sc-220362B
10 mg
100 mg
1 g
$39.00
$90.00
$120.00
4
(1)

Valsartan, an angiotensin II receptor antagonist, influences blood pressure control. This action can indirectly modulate GPCR-mediated signaling pathways, potentially impacting olfactory receptor activities.

Sotalol hydrochloride

959-24-0sc-203699
sc-203699A
10 mg
50 mg
$67.00
$246.00
3
(1)

Sotalol is a non-selective beta-adrenergic blocker with antiarrhythmic properties. It can influence GPCR signaling indirectly, potentially affecting olfactory receptor function through altered adrenergic pathway dynamics.

Betaxolol

63659-18-7sc-210913
10 mg
$212.00
1
(1)

Betaxolol is a selective beta-1 adrenergic receptor antagonist. Its specific targeting of beta-1 receptors can indirectly affect GPCR signaling, potentially modulating olfactory receptor activities.

Olmesartan acid

144689-24-7sc-219481
sc-219481A
sc-219481B
sc-219481C
sc-219481D
10 mg
500 mg
1 g
2 g
5 g
$153.00
$204.00
$326.00
$523.00
$1051.00
7
(1)

Olmesartan, an angiotensin II receptor antagonist, is used for managing hypertension. Its action can indirectly influence GPCR signaling, potentially impacting the functionality of olfactory receptors.

Nebivolol

99200-09-6sc-279910
100 mg
$803.00
1
(0)

Nebivolol is a selective beta-1 adrenergic receptor antagonist with vasodilatory effects. Its influence on adrenergic pathways can indirectly affect GPCR signaling relevant to olfactory receptors.